Original Research Article I Volume 1 I Issue 3 I 2015
Metabolic effects of protease inhibitors in human immunodeficiency virus (HIV) infected patients
T. Shivalingu
American Journal of Science and Medical Research; 1(3); 101-107
DOI:http://dx.doi.org/10.17812/ajsmr2015133
Abstract:
The present study focuses on the prevalence and characteristics of the metabolic syndrome in HIV-infected patients and possible related factors, including individual antiretroviral drug exposure. A cross-sectional study was carried out on 720 HIV-infected patients managed at the outpatient Infectious Disease Unit of the Mahatma Gandhi Memorial Hospital, Warangal, Andhra Pradesh, over a period of 1 year, from September through August 2007. Age, sex, HIV disease status according to Disease Control and Prevention (CDC) classification of HIV disease, HIV exposure (mutually exclusive in the following order:
Keywords:
Protease inhibitors, HIV, ART, Metabolic syndrome, Adilabad
References:
1. Allen SD, Wilkerson JL: The importance of glucose-6-phosphate dehydrogenase screening in a urologic practice. J Urol 107:304, 1972.
2. Baratha Jyothi N, Ram Babu Ch, Somaiah K, Suresh Babu K. A study on prevalence of anemia and growth pattern among HIV-infected children from rural areas attending Govt. General hospital, Vijayawada, Andhra Pradesh, India. Biolife 2 (2), 493-501, 2014.
3. Bonadonna RC, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA. Obesity and insulin resistance in humans: a dose-response study. Metabolism 39:452–459. 1990.
4. Doukas MA: Human immunodeficiency virus associated anemia. Med Clin North Am 76:699, 1992.
5. Dunnigan MG, Cochrane M, Kelly A, Scott JW. Familial lipoatrophic diabetes with dominant transmission. QJM 43:33–48, 1997.
6. Estari Mamidala and Krishna Reddy Matta. Seroprevalence of HIV / AIDS infection among tribals in rural areas of Adilabad district (A.P.) India. Asian J. of Bio Scie, Vol.1 No.2:32-34, 2006.
7. Frontiera M, Myers AM: Peripheral blood and bone marrow abnormalities in the acquired immunodeficiency syndrome. West J Med 147:157, 1987.
8. Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fisch MA Gabin SS, Gottleib MS: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med 117:739, 1992.
9. Mamidala Estari, Lunavath Venkanna, Annem Srinivas Reddy. In vitro anti-HIV activity of crude extracts from Tinospora cordifolia. BMC Infectious Diseases 05/2012; 12(1):10. DOI: 10.1186/1471-2334-12-S1-P10.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419, 1985....
Article Dates:
Received: 24 July 2015; Accepted: 28 August 2015; Published: 20 September 2015
How To Cite:
T. Shivalingu (2015). Metabolic effects of protease inhibitors in human immunodeficiency virus (HIV) infected patients. The American Journal of Science and Medical Research, 1(3):101-107. doi:10.17812/ajsmr2015133 Received 24 July, 2015; Accepted 28 August, 2015 Published online 20 September, 2015
